메뉴 건너뛰기
Clinical Immunology
Volumn 129, Issue 3, 2008, Pages 518-519
Subcutaneous immunoglobulin therapy for immunomodulation in a patient with severe epidermolysis bullosa acquisita
Author keywords

[No Author keywords available]
Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; MERCAPTOPURINE; MINOCYCLINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
EID: 55249092037     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2008.08.003     Document Type: Letter
Times cited : (22)
References (7)
  • 1
    • 0036120802 scopus 로고    scopus 로고
    • Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review
    • Kirtschig G., et al. Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review. Arch. Dermatol. 138 3 (2002) 380-384
    • (2002) Arch. Dermatol. , vol.138 , Issue.3 , pp. 380-384
    • Kirtschig, G.1
  • 2
    • 0003638576 scopus 로고    scopus 로고
    • G. Kirtschig, D. Murrell, F. Wojnarowska, N. Khumalo, Cochrane Database of Systematic Reviews 1, (2003), doi:10.1002/14651858.
    • G. Kirtschig, D. Murrell, F. Wojnarowska, N. Khumalo, Cochrane Database of Systematic Reviews 1, (2003), doi:10.1002/14651858.
  • 3
    • 0034073949 scopus 로고    scopus 로고
    • The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy
    • Chapel H.M., et al. The comparison of the efficacy and safety of intravenous versus subcutaneous immunoglobulin replacement therapy. J. Clin. Immunol. 20 2 (2000) 94-100
    • (2000) J. Clin. Immunol. , vol.20 , Issue.2 , pp. 94-100
    • Chapel, H.M.1
  • 4
    • 0028857579 scopus 로고
    • Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs
    • Gardulf A., et al. Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet 345 8946 (1995) 365-369
    • (1995) Lancet , vol.345 , Issue.8946 , pp. 365-369
    • Gardulf, A.1
  • 5
    • 33745145825 scopus 로고    scopus 로고
    • Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases
    • Ochs H.D., et al. Safety and efficacy of self-administered subcutaneous immunoglobulin in patients with primary immunodeficiency diseases. J. Clin. Immunol. 26 3 (2006) 265-273
    • (2006) J. Clin. Immunol. , vol.26 , Issue.3 , pp. 265-273
    • Ochs, H.D.1
  • 6
    • 39749172022 scopus 로고    scopus 로고
    • Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy
    • Lee D.H., et al. Subcutaneous immunoglobulin infusion: a new therapeutic option in chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 37 3 (2008) 406-409
    • (2008) Muscle Nerve , vol.37 , Issue.3 , pp. 406-409
    • Lee, D.H.1
  • 7
    • 47349115693 scopus 로고    scopus 로고
    • Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?
    • Schleinitz N., et al. Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?. Clin. Rheumatol. 27 8 (2008) 1067-1068
    • (2008) Clin. Rheumatol. , vol.27 , Issue.8 , pp. 1067-1068
    • Schleinitz, N.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.